The evolution of treatment for hepatitis C virus during the past 15 years has been astounding, and we now are able to talk about how HCV could be eliminated.
Lauren M. Hynicka, PHARMD, BCPS, RYT-200
Advertisement
Hynicka is an associate professor of pharmacotherapy at the University of Maryland School of Pharmacy in Baltimore. She served as a clinical pharmacy specialist on a general internal medicine team at the University of Maryland Medical Center in Baltimore for 6 years before transitioning into her current role managing the treatment of patients with HCV in an ambulatory clinic.
Articles by Lauren M. Hynicka, PHARMD, BCPS, RYT-200
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
2
Meet SIDP’s President Elect: Lisa Dumkow, PharmD, FIDP, BCIDP
3
Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix
4
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
5
